Skip to main content
Premium Trial:

Request an Annual Quote

Hyseq and Kirin Brewery Collaborate on Gene Discovery Project

Premium

SUNNYVALE, Calif.--Hyseq and Japan's Kirin Brewery have announced a collaboration in which Hyseq will use its proprietary gene discovery platform to target novel genes involved in cell growth regulation from specific cell lines provided by Kirin. Kirin and Hyseq will together develop and market pharmaceutical products emanating from the collaboration, the companies said.

Under terms of the agreement, Kirin will pay Hyseq $3 million for the initial phase of the collaboration plus additional amounts for milestones relating to clinical development and commercialization in Kirin territories of pharmaceutical products resulting from the collaboration.

The two-year deal is exclusive to the discovery of genes from the proprietary cell lines provided by Kirin. Hyseq will also receive royalties from the sale of associated pharmaceutical products in Kirin territories.

Filed under

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.